JP2020040952A5 - - Google Patents

Download PDF

Info

Publication number
JP2020040952A5
JP2020040952A5 JP2019193276A JP2019193276A JP2020040952A5 JP 2020040952 A5 JP2020040952 A5 JP 2020040952A5 JP 2019193276 A JP2019193276 A JP 2019193276A JP 2019193276 A JP2019193276 A JP 2019193276A JP 2020040952 A5 JP2020040952 A5 JP 2020040952A5
Authority
JP
Japan
Prior art keywords
polypeptide
membrane
chromatography
ion exchange
exchange membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019193276A
Other languages
English (en)
Japanese (ja)
Other versions
JP7402011B2 (ja
JP2020040952A (ja
Filing date
Publication date
Priority claimed from JP2018023128A external-priority patent/JP2018109024A/ja
Application filed filed Critical
Publication of JP2020040952A publication Critical patent/JP2020040952A/ja
Priority to JP2021102974A priority Critical patent/JP7359807B2/ja
Publication of JP2020040952A5 publication Critical patent/JP2020040952A5/ja
Priority to JP2022050501A priority patent/JP2022101557A/ja
Application granted granted Critical
Publication of JP7402011B2 publication Critical patent/JP7402011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019193276A 2011-12-22 2019-10-24 イオン交換膜クロマトグラフィー Active JP7402011B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021102974A JP7359807B2 (ja) 2011-12-22 2021-06-22 イオン交換膜クロマトグラフィー
JP2022050501A JP2022101557A (ja) 2011-12-22 2022-03-25 イオン交換膜クロマトグラフィー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579285P 2011-12-22 2011-12-22
US61/579,285 2011-12-22
JP2018023128A JP2018109024A (ja) 2011-12-22 2018-02-13 イオン交換膜クロマトグラフィー

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018023128A Division JP2018109024A (ja) 2011-12-22 2018-02-13 イオン交換膜クロマトグラフィー

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2021102974A Division JP7359807B2 (ja) 2011-12-22 2021-06-22 イオン交換膜クロマトグラフィー
JP2022050501A Division JP2022101557A (ja) 2011-12-22 2022-03-25 イオン交換膜クロマトグラフィー

Publications (3)

Publication Number Publication Date
JP2020040952A JP2020040952A (ja) 2020-03-19
JP2020040952A5 true JP2020040952A5 (enExample) 2021-09-09
JP7402011B2 JP7402011B2 (ja) 2023-12-20

Family

ID=47430154

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014549204A Active JP6605202B2 (ja) 2011-12-22 2012-12-18 イオン交換膜クロマトグラフィー
JP2018023128A Withdrawn JP2018109024A (ja) 2011-12-22 2018-02-13 イオン交換膜クロマトグラフィー
JP2019193276A Active JP7402011B2 (ja) 2011-12-22 2019-10-24 イオン交換膜クロマトグラフィー
JP2021102974A Active JP7359807B2 (ja) 2011-12-22 2021-06-22 イオン交換膜クロマトグラフィー
JP2022050501A Pending JP2022101557A (ja) 2011-12-22 2022-03-25 イオン交換膜クロマトグラフィー

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014549204A Active JP6605202B2 (ja) 2011-12-22 2012-12-18 イオン交換膜クロマトグラフィー
JP2018023128A Withdrawn JP2018109024A (ja) 2011-12-22 2018-02-13 イオン交換膜クロマトグラフィー

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021102974A Active JP7359807B2 (ja) 2011-12-22 2021-06-22 イオン交換膜クロマトグラフィー
JP2022050501A Pending JP2022101557A (ja) 2011-12-22 2022-03-25 イオン交換膜クロマトグラフィー

Country Status (21)

Country Link
US (3) US10364268B2 (enExample)
EP (2) EP3492486A1 (enExample)
JP (5) JP6605202B2 (enExample)
KR (3) KR20210025692A (enExample)
CN (2) CN108892706A (enExample)
AR (1) AR089362A1 (enExample)
AU (3) AU2012355356B2 (enExample)
BR (1) BR112014015101A8 (enExample)
CA (1) CA2859376C (enExample)
ES (1) ES2697676T3 (enExample)
HR (1) HRP20181846T1 (enExample)
IL (2) IL267585B (enExample)
MX (2) MX360453B (enExample)
MY (1) MY172426A (enExample)
PL (1) PL2794635T3 (enExample)
RU (1) RU2648999C2 (enExample)
SG (1) SG11201403437TA (enExample)
SI (1) SI2794635T1 (enExample)
TR (1) TR201815709T4 (enExample)
WO (1) WO2013096322A1 (enExample)
ZA (2) ZA201404593B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL267585B (en) * 2011-12-22 2022-09-01 Genentech Inc Ion exchange membrane chromatography
CN110054661A (zh) 2013-12-12 2019-07-26 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
CN106029682B (zh) 2013-12-27 2021-04-13 中外制药株式会社 等电点低的抗体的纯化方法
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
EP3334747B1 (en) 2015-08-13 2023-09-27 Amgen Inc. Charged depth filtration of antigen-binding proteins
GB201711481D0 (en) 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
KR102140531B1 (ko) * 2018-08-07 2020-08-04 (주)휴온스 Gly-Tβ4의 제조방법
EP3837273B1 (en) * 2018-08-14 2025-09-24 Bristol-Myers Squibb Company Improved protein recovery
GB201815405D0 (en) * 2018-09-21 2018-11-07 Fujifilm Mfg Europe Bv Membranes suitable for detecting, filtering and/or purifying biomolecules
US12306152B2 (en) 2018-12-21 2025-05-20 Solventum Intellectual Properties Company Method for testing a chromatography device used for ion exchange
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
CN115335394A (zh) * 2020-01-24 2022-11-11 奥克梅斯制药爱尔兰有限公司 纯化方法
US11416468B2 (en) * 2020-07-21 2022-08-16 International Business Machines Corporation Active-active system index management
CN116371011B (zh) * 2023-05-26 2023-08-18 湖南杰萃生物技术有限公司 一种从桑叶中提取黄酮和生物碱的方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (enExample)
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
JPS6150925A (ja) 1984-08-17 1986-03-13 Toray Ind Inc 抗原または抗体の精製方法
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
EP0391934A1 (en) * 1987-10-23 1990-10-17 Schering Corporation Method of purifying protein
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JP2844346B2 (ja) 1989-05-31 1999-01-06 昭 梶 新規ペプチドならびに新規dna
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
ES2193136T3 (es) 1991-08-14 2003-11-01 Genentech Inc Variantes de inmunoglubina para receptores especificos de fc epsilon.
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
ATE419355T1 (de) 1992-02-06 2009-01-15 Novartis Vaccines & Diagnostic Marker für krebs und biosynthetisches bindeprotein dafür
EP0656789B1 (en) 1992-08-21 1997-12-17 Genentech, Inc. Method for treating a lfa-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
DE69416103T2 (de) 1993-09-21 1999-08-05 Hemosol Inc., Etobicoke, Ontario Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
US5714338A (en) 1993-12-10 1998-02-03 Genentech, Inc. Methods for diagnosis of allergy
EP0739214B1 (en) 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
EP0749488A1 (en) 1994-03-03 1996-12-27 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5641870A (en) * 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
AU6267896A (en) 1995-06-07 1996-12-30 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth oftumors
EP1297847A3 (en) 1996-01-23 2003-05-07 Genentech, Inc. Anti-CD18 antibodies in stroke
US6592905B1 (en) 1996-01-31 2003-07-15 Massey University Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
KR100532178B1 (ko) 1996-11-27 2005-12-01 제넨테크, 인크. 인간화 항-CD11a 항체
ES2236634T3 (es) 1997-04-07 2005-07-16 Genentech, Inc. Anticuerpos anti-vegf.
ES2293682T5 (es) 1997-05-15 2011-11-17 Genentech, Inc. Anticuerpo anti-apo2.
US6054293A (en) 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
GEP20104998B (en) 1999-06-25 2010-06-10 Genentech Inc Humanized antibody which binds erbb2 and blocks activation by ligand receptor of erbb2 (variants) and use of the composition comprising these antibodies methods for treating cancer
DK1226177T3 (da) 1999-10-29 2008-10-06 Genentech Inc Antistofsammensætninger mod anti-prostata stamcelle-antigen (PSCA) og anvendelser deraf
US20020012982A1 (en) 2000-07-13 2002-01-31 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
WO2003025156A2 (en) 2001-09-18 2003-03-27 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
AU2002332130A1 (en) 2001-10-16 2003-04-28 Exelixis, Inc. Msrebps as modifiers of the srebp pathway and methods of use
WO2003033658A2 (en) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CN100522999C (zh) 2002-02-14 2009-08-05 免疫医疗公司 抗cd20抗体及其融合蛋白和使用方法
WO2004035607A2 (en) 2002-10-17 2004-04-29 Genmab A/S Human monoclonal antibodies against cd20
PT1572744E (pt) 2002-12-16 2010-09-07 Genentech Inc Variantes de imunoglobulina e utilizações destas
CN1206240C (zh) * 2003-04-07 2005-06-15 中国科学院生态环境研究中心 高效离子交换膜色谱纯化卵黄蛋白原技术
NZ543960A (en) 2003-05-09 2008-11-28 Univ Duke CD20-specific antibodies and methods of employing same
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
JP4818917B2 (ja) 2003-08-08 2011-11-16 イミューノメディクス、インコーポレイテッド 腫瘍および罹患細胞のアポトーシスを誘発するための二重特異性抗体
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
US20080274501A1 (en) * 2007-05-02 2008-11-06 Chenming Zhang Method of purifying acidic proteins expressed in plants
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
US8653246B2 (en) 2007-10-26 2014-02-18 Asahi Kasei Chemicals Corporation Method for purifying protein
CL2008003218A1 (es) 2007-10-30 2009-03-06 Genentech Inc Método para la purificación de un anticuerpo a partir de una composición que comprende el anticuerpo y al menos un contaminante.
WO2009135656A1 (en) * 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
KR101843915B1 (ko) 2008-08-14 2018-04-02 제넨테크, 인크. 고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
KR101844859B1 (ko) 2009-08-06 2018-05-18 제넨테크, 인크. 단백질 정제 시의 바이러스 제거의 개선방법
CA2772653C (en) * 2009-09-01 2019-06-25 Genentech, Inc. Enhanced protein purification through a modified protein a elution
DK2560683T4 (da) * 2010-04-23 2022-08-29 Hoffmann La Roche Fremstilling af heteromultimeriske proteiner
MY161534A (en) 2010-05-25 2017-04-28 Genentech Inc Methods of purifying polypeptides
KR20140084125A (ko) * 2011-10-03 2014-07-04 사켐,인코포레이티드 소수성 치환 크로마토그래피용 중성 양쪽성 이온 디스플레이서 분자
IL267585B (en) 2011-12-22 2022-09-01 Genentech Inc Ion exchange membrane chromatography
JP5731726B1 (ja) 2014-06-26 2015-06-10 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Similar Documents

Publication Publication Date Title
JP2020040952A5 (enExample)
JP2015503524A5 (enExample)
US7662930B2 (en) Polishing steps used in multi-step protein purification processes
US8217153B2 (en) Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents
US20100069617A1 (en) Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
EP1718668B1 (en) Antibody purification
KR101569783B1 (ko) 항체의 정제 방법
US20110166332A1 (en) Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
Belew et al. High-performance analytical applications of immobilized metal ion affinity chromatography
Porath Cross-linked dextrans as molecular sieves
ES2373402T3 (es) Método para purificar anticuerpos.
RU2014130017A (ru) Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии
KR20130069515A (ko) 항체의 정제 방법
RU2011112989A (ru) Способы очистки однодоменных антигенсвязывающих молекул
EP0368092B1 (en) Ion exchange and separation method
JP2016514101A (ja) タンパク質製剤からエンドトキシンを除去するための物質および方法
Fan et al. Purification of a monoclonal antibody using a novel high-capacity multimodal cation exchange nonwoven membrane
Fang et al. A new tetrapeptide biomimetic chromatographic resin for antibody separation with high adsorption capacity and selectivity
US20090234033A1 (en) Separating Agent for IgG Purification and Method for Purifying an IgG Monomer by Using It
US20250243240A1 (en) Method for purifying fusion protein having igg fc domain
Adamikova et al. Selection of adsorbents for recombinant human erythropoietin purification
Gagnon et al. Recent advances in the purification of IgM monoclonal antibodies
CN120309683A (zh) 一种使用Protein A亲和层析纯化抗体的方法及其应用
KR20150070711A (ko) 혼합 방식 크로마토그래피를 이용한 침출된 단백질 a 제거 방법
Berg Purification of rh-TNF-α by chromatographic methods